Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
Ole Niewoehner(University of Zurich), Martin Jínek(University of Zurich), Jonathan Hall(Novartis (Switzerland)), Carmela Garcia‐Doval(University of Zurich), Jakob T. Rostøl(Imperial College London), Frank Schwede(Biolog Life Science Institute), Christian Berk(ETH Zurich), Luciano A. Marraffini(Howard Hughes Medical Institute), Laurent Bigler(University of Zurich)
Cited by 504
Related Papers
RNA-programmed genome editing in human cells
|eLife|2013|2.1k
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
|Nature|2014|1.9k